Results 291 to 300 of about 88,090 (336)
Some of the next articles are maybe not open access.
Annual Review of Medicine, 1987
Malignancy-associated hypercalcemia is a common and important clinical problem. Two major pathogenic mechanisms appear to be operative in this disorder: local osteolytic hypercalcemia and humoral hypercalcemia of malignancy. The clinical and biochemical features that distinguish these two processes are reviewed.
Karl L. Insogna, A E Broadus
openaire +3 more sources
Malignancy-associated hypercalcemia is a common and important clinical problem. Two major pathogenic mechanisms appear to be operative in this disorder: local osteolytic hypercalcemia and humoral hypercalcemia of malignancy. The clinical and biochemical features that distinguish these two processes are reviewed.
Karl L. Insogna, A E Broadus
openaire +3 more sources
Seminars in Oncology Nursing, 1999
To provide a review of hypercalcemia of malignancy, including the incidence, pathophysiology, signs and symptoms, treatment, and nursing interventions.Research studies, review articles, proceedings from nursing conferences, and book chapters.Hypercalcemia of malignancy is difficult to diagnose because the signs and symptoms are similar to those ...
openaire +2 more sources
To provide a review of hypercalcemia of malignancy, including the incidence, pathophysiology, signs and symptoms, treatment, and nursing interventions.Research studies, review articles, proceedings from nursing conferences, and book chapters.Hypercalcemia of malignancy is difficult to diagnose because the signs and symptoms are similar to those ...
openaire +2 more sources
Endocrinology and Metabolism Clinics of North America, 2021
Hypercalcemia of malignancy (HCM) is considered an oncologic emergency associated with significant symptom burden and increased comorbid conditions and mortality. Underlying pathologic processes most often stimulate osteoclast-mediated bone resorption.
openaire +2 more sources
Hypercalcemia of malignancy (HCM) is considered an oncologic emergency associated with significant symptom burden and increased comorbid conditions and mortality. Underlying pathologic processes most often stimulate osteoclast-mediated bone resorption.
openaire +2 more sources
The Journal of Steroid Biochemistry and Molecular Biology, 1992
Hypercalcemia may occur as a complication of haematological malignancies, in association with solid tumors with bone metastases, and with solid tumors in the absence of bone metastases. The latter syndrome, known as the humoral hypercalcemia of malignancy (HHM) shares many features with primary hyperparathyroidism. A parathyroid hormone-related protein
T.J. Martin, V. Grill
openaire +3 more sources
Hypercalcemia may occur as a complication of haematological malignancies, in association with solid tumors with bone metastases, and with solid tumors in the absence of bone metastases. The latter syndrome, known as the humoral hypercalcemia of malignancy (HHM) shares many features with primary hyperparathyroidism. A parathyroid hormone-related protein
T.J. Martin, V. Grill
openaire +3 more sources
Hypercalcemia and Hypertension
Annals of Internal Medicine, 1966Excerpt Hypertension as a sign of hypercalcemia has received little emphasis in the literature. Many current textbooks of medicine and endocrinology fail to mention the association while stressing ...
Robert H. Moser +2 more
openaire +3 more sources
Drug Intelligence & Clinical Pharmacy, 1983
The indications, effectiveness, and adverse effects of the numerous treatment modalities for hypercalcemia are presented. Results of a retrospective chart review of 72 admissions (53 patients) for hypercalcemia-related diseases are presented to emphasize the therapeutic principles that should be applied in the management of these patients.
Michael W. McKenzie, Gary T. Elliott
openaire +3 more sources
The indications, effectiveness, and adverse effects of the numerous treatment modalities for hypercalcemia are presented. Results of a retrospective chart review of 72 admissions (53 patients) for hypercalcemia-related diseases are presented to emphasize the therapeutic principles that should be applied in the management of these patients.
Michael W. McKenzie, Gary T. Elliott
openaire +3 more sources
Frontiers of Hormone Research, 2018
Primary hyperparathyroidism is among the most common causes of hypercalcemia. However, ingestion of medication, including hydrochlorathiazide, lithium, and foscarnet, excessive vitamin A ingestion, endocrinopathies such as hyperthyroidism, adrenal ...
D. Goltzman
semanticscholar +1 more source
Primary hyperparathyroidism is among the most common causes of hypercalcemia. However, ingestion of medication, including hydrochlorathiazide, lithium, and foscarnet, excessive vitamin A ingestion, endocrinopathies such as hyperthyroidism, adrenal ...
D. Goltzman
semanticscholar +1 more source
Postgraduate Medicine, 1979
Hypercalcemia calls first for supportive measures, eg, adequate hydration, movement or mobilization of the patient to the greatest amount tolerated, and reevaluation of drugs being taken. When immediate lowering of the serum calcium level is not clinically mandatory, oral administration of furosemide, corticosteroid, or phosphorus should be considered.
Charles R. Kleeman +2 more
openaire +3 more sources
Hypercalcemia calls first for supportive measures, eg, adequate hydration, movement or mobilization of the patient to the greatest amount tolerated, and reevaluation of drugs being taken. When immediate lowering of the serum calcium level is not clinically mandatory, oral administration of furosemide, corticosteroid, or phosphorus should be considered.
Charles R. Kleeman +2 more
openaire +3 more sources
Endocrinology and Metabolism Clinics of North America, 2021
Marcocci C., Cetani F.
openaire +3 more sources
Marcocci C., Cetani F.
openaire +3 more sources
Investigation of hypercalcemia
Clinical Biochemistry, 2012Hypercalcemia is a relatively common clinical finding. Primary hyperparathyroidism, hypercalcemia associated with malignancy and chronic renal failure (with calcium and vitamin D metabolite treatment or tertiary hyperparathyroidism) are the most common causes.
openaire +3 more sources